CLINICAL_TRIALS trial_result · 2017-07-31

Clinical Trial Update: Safety Study of Candidate Malaria Vaccine FMP1/AS02A in Healthy Adults in Bandiagara, Mali [Phase 1]

A Phase 1 safety study of the malaria vaccine FMP1/AS02A in healthy adults in Mali has been completed. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Malaria | Phase 1 | Status: COMPLETED | Results posted: 2017-07-31